# EDGAR Filing Document

**Accession Number:** 0000945908
**File Stem:** 0001410368-25-040130
**Filing Date:** 2025-12
**Character Count:** 180238
**Document Hash:** 52e65095abce09997df309c47f5fb50f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-25-040130.hdr.sgml**: 20251222

**ACCESSION NUMBER**: 0001410368-25-040130

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251031

**FILED AS OF DATE**: 20251222

**DATE AS OF CHANGE**: 20251222

**PERIOD START**: 20260731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FIDELITY COVINGTON TRUST
- **CENTRAL INDEX KEY:** 0000945908

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07319
- **FILM NUMBER:** 251589914

**BUSINESS ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 617-563-7000

**MAIL ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

## Series and Classes Contracts Data

### Fidelity MSCI Health Care Index ETF (Series ID: S000042575)

| Class ID   | Class Name                          | Ticker Symbol   |
|:---|:---|:---|
| C000131667 | Fidelity MSCI Health Care Index ETF | FHLC            |

## Nport-Ex

### Quarterly Holdings Report

### for

### Fidelity® MSCI Health Care Index ETF

### October 31, 2025
T05-NPRT1-1225

1.9584811.111 ------

### Schedule of Investments October 31, 2025 (Unaudited)
Showing Percentage of Net Assets

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – 99.8%** | &nbsp;&nbsp;**Common Stocks – 99.8%** | &nbsp;&nbsp;**Common Stocks – 99.8%** |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **BIOTECHNOLOGY – 22.0%** | **BIOTECHNOLOGY – 22.0%** | **BIOTECHNOLOGY – 22.0%** |
| **Biotechnology – 22.0%** | **Biotechnology – 22.0%** | **Biotechnology – 22.0%** |
| AbbVie, Inc. | 744059 | &nbsp;&nbsp;&nbsp;$162234624 |
| ACADIA Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;49434 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1122152 |
| ADMA Biologics, Inc. (a) | 100363 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1553619 |
| Agios Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;23216 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1003860 |
| Akebia Therapeutics, Inc. (a) | 110819 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;244910 |
| Akero Therapeutics, Inc. (a) | &nbsp;&nbsp;23482 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1272724 |
| Akouos, Inc. (a) | &nbsp;&nbsp;11863 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2254 |
| Alkermes PLC (a) | &nbsp;&nbsp;65956 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024849 |
| Alnylam Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;54926 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25048453 |
| Amgen, Inc. | 226497 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67593500 |
| Amicus Therapeutics, Inc. (a) | 104332 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;942118 |
| AnaptysBio, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;5807 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;212420 |
| Anavex Life Sciences Corp. (a) | &nbsp;&nbsp;35572 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;283509 |
| Apellis Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;31703 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;680663 |
| Apogee Therapeutics, Inc. (a) | &nbsp;&nbsp;13090 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;740763 |
| Arbutus Biopharma Corp. (a) | &nbsp;&nbsp;59302 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;280498 |
| Arcellx, Inc. (a) | &nbsp;&nbsp;11625 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1049156 |
| Arcus Biosciences, Inc. (a) | &nbsp;&nbsp;29041 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;572689 |
| Arcutis Biotherapeutics, Inc. (a) | &nbsp;&nbsp;45276 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1145936 |
| Ardelyx, Inc. (a) | 102181 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;619217 |
| ArriVent Biopharma, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7743 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;145026 |
| Arrowhead Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;46764 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1982326 |
| ARS Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;18721 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;167740 |
| Aurinia Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;47865 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;630382 |
| Avidity Biosciences, Inc. (a) | &nbsp;&nbsp;45505 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3178524 |
| Beam Therapeutics, Inc. (a) | &nbsp;&nbsp;37764 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;944478 |
| BioCryst Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;84378 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;617647 |
| Biogen, Inc. (a) | &nbsp;&nbsp;61643 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9509666 |
| Biohaven Ltd. (a) | &nbsp;&nbsp;36087 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;620696 |
| BioMarin Pharmaceutical, Inc. (a) | &nbsp;&nbsp;80707 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4323474 |
| Bridgebio Pharma, Inc. (a) | &nbsp;&nbsp;60089 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3763975 |
| CareDx, Inc. (a) | &nbsp;&nbsp;22165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;332475 |
| Catalyst Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;48802 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1038019 |
| Celldex Therapeutics, Inc. (a) | &nbsp;&nbsp;24989 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;667956 |
| CG oncology, Inc. (a) | &nbsp;&nbsp;17482 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;756446 |
| Chinook Therapeutics, Inc. (a) | &nbsp;&nbsp;24218 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 |
| Cidara Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;4956 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;541393 |
| Cogent Biosciences, Inc. (a) | &nbsp;&nbsp;35296 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;575325 |
| Crinetics Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;37212 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1618722 |
| CRISPR Therapeutics AG (a) | &nbsp;&nbsp;34687 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2219621 |
| Cullinan Therapeutics, Inc. (a) | &nbsp;&nbsp;10512 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;91034 |
| Cytokinetics, Inc. (a) | &nbsp;&nbsp;47944 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3048759 |
| Day One Biopharmaceuticals, Inc. (a) | &nbsp;&nbsp;27918 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;207710 |
| Denali Therapeutics, Inc. (a) | &nbsp;&nbsp;58235 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;948066 |
| Disc Medicine, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9456 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;815296 |
| Dynavax Technologies Corp. (a) | &nbsp;&nbsp;41248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;423204 |
| Dyne Therapeutics, Inc. (a) | &nbsp;&nbsp;39509 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;892113 |
| Exact Sciences Corp. (a) | &nbsp;&nbsp;79595 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5149001 |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Exelixis, Inc. (a) | 109316 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4227250 |
| Geron Corp. (a) | 195055 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;245769 |
| Gilead Sciences, Inc. | 523977 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;62767205 |
| GRAIL, Inc. (a) | &nbsp;&nbsp;15395 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1415262 |
| Halozyme Therapeutics, Inc. (a) | &nbsp;&nbsp;52078 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3394965 |
| Ideaya Biosciences, Inc. (a) | &nbsp;&nbsp;33057 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1053196 |
| ImmunityBio, Inc. (a) | 111727 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;268145 |
| Immunome, Inc. (a) | &nbsp;&nbsp;30018 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;482389 |
| Immunovant, Inc. (a) | &nbsp;&nbsp;28224 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;696568 |
| Incyte Corp. (a) | &nbsp;&nbsp;69243 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6472836 |
| Insmed, Inc. (a) | &nbsp;&nbsp;80095 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15186012 |
| Intellia Therapeutics, Inc. (a) | &nbsp;&nbsp;41469 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;523339 |
| Ionis Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;63610 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4726223 |
| Iovance Biotherapeutics, Inc. (a) | 110465 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;217616 |
| Janux Therapeutics, Inc. (a) | &nbsp;&nbsp;16230 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;465963 |
| KalVista Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;10539 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;114981 |
| Kiniksa Pharmaceuticals International PLC (a) | &nbsp;&nbsp;14259 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;527726 |
| Krystal Biotech, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9196 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1816302 |
| Kura Oncology, Inc. (a) | &nbsp;&nbsp;29225 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;300141 |
| Kymera Therapeutics, Inc. (a) | &nbsp;&nbsp;17763 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1098464 |
| LENZ Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;4920 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;146222 |
| Madrigal Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;6107 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2558222 |
| MannKind Corp. (a) | 119390 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;667390 |
| Merus NV (a) | &nbsp;&nbsp;21999 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2086825 |
| Metsera, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8845 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;557589 |
| MiMedx Group, Inc. (a) | &nbsp;&nbsp;48307 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;369549 |
| Mineralys Therapeutics, Inc. (a) | &nbsp;&nbsp;19288 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;788108 |
| Mirum Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;15656 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1137408 |
| Moderna, Inc. (a) | 146480 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3978397 |
| MoonLake Immunotherapeutics (a) | &nbsp;&nbsp;&nbsp;&nbsp;9252 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;93445 |
| Myriad Genetics, Inc. (a) | &nbsp;&nbsp;37957 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;305174 |
| Natera, Inc. (a) | &nbsp;&nbsp;54591 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10859788 |
| Neurocrine Biosciences, Inc. (a) | &nbsp;&nbsp;41649 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5964553 |
| Newamsterdam Pharma Co. NV (a) | &nbsp;&nbsp;19479 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;739228 |
| Novavax, Inc. (a) | &nbsp;&nbsp;60231 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;505940 |
| Nurix Therapeutics, Inc. (a) | &nbsp;&nbsp;31794 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;411414 |
| Nuvalent, Inc. Class A (a) | &nbsp;&nbsp;16727 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1661326 |
| ORIC Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;14385 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;189307 |
| Praxis Precision Medicines, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8663 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1721858 |
| Protagonist Therapeutics, Inc. (a) | &nbsp;&nbsp;21023 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1652828 |
| PTC Therapeutics, Inc. (a) | &nbsp;&nbsp;29926 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2044245 |
| Recursion Pharmaceuticals, Inc. Class A (a) | 135049 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;745470 |
| Regeneron Pharmaceuticals, Inc. | &nbsp;&nbsp;44717 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29146541 |
| Relay Therapeutics, Inc. (a) | &nbsp;&nbsp;48685 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;347611 |
| Replimune Group, Inc. (a) | &nbsp;&nbsp;16211 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;157733 |
| Revolution Medicines, Inc. (a) | &nbsp;&nbsp;58758 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3457321 |
| Rhythm Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;22275 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2534004 |
| Roivant Sciences Ltd. (a) | 129082 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2580349 |
| Sana Biotechnology, Inc. (a) | &nbsp;&nbsp;57103 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;282660 |
| Sarepta Therapeutics, Inc. (a) | &nbsp;&nbsp;36784 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;883184 |

---

 ***Quarterly Report*** <sub>2</sub>

------

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** |
| **Biotechnology – continued** | **Biotechnology – continued** | **Biotechnology – continued** | **Biotechnology – continued** |
| Scholar Rock Holding Corp. (a) | Scholar Rock Holding Corp. (a) | &nbsp;&nbsp;26041 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$771334 |
| Soleno Therapeutics, Inc. (a) | Soleno Therapeutics, Inc. (a) | &nbsp;&nbsp;16693 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1121102 |
| Spyre Therapeutics, Inc. (a) | Spyre Therapeutics, Inc. (a) | &nbsp;&nbsp;20597 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;503803 |
| Stoke Therapeutics, Inc. (a) | Stoke Therapeutics, Inc. (a) | &nbsp;&nbsp;16125 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;484395 |
| Syndax Pharmaceuticals, Inc. (a) | Syndax Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;34493 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;472554 |
| TG Therapeutics, Inc. (a) | TG Therapeutics, Inc. (a) | &nbsp;&nbsp;63168 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2196983 |
| Travere Therapeutics, Inc. (a) | Travere Therapeutics, Inc. (a) | &nbsp;&nbsp;35768 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1257603 |
| Twist Bioscience Corp. (a) | Twist Bioscience Corp. (a) | &nbsp;&nbsp;25383 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;834847 |
| Ultragenyx Pharmaceutical, Inc. (a) | Ultragenyx Pharmaceutical, Inc. (a) | &nbsp;&nbsp;35583 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1231172 |
| uniQure NV (a) | uniQure NV (a) | &nbsp;&nbsp;16578 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1122165 |
| United Therapeutics Corp. (a) | United Therapeutics Corp. (a) | &nbsp;&nbsp;18081 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8053820 |
| Vaxcyte, Inc. (a) | Vaxcyte, Inc. (a) | &nbsp;&nbsp;48813 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2210253 |
| Vera Therapeutics, Inc. (a) | Vera Therapeutics, Inc. (a) | &nbsp;&nbsp;17492 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;497822 |
| Veracyte, Inc. (a) | Veracyte, Inc. (a) | &nbsp;&nbsp;33263 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1200129 |
| Vericel Corp. (a) | Vericel Corp. (a) | &nbsp;&nbsp;21054 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;738153 |
| Vertex Pharmaceuticals, Inc. (a) | Vertex Pharmaceuticals, Inc. (a) | 108170 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;46033907 |
| Viking Therapeutics, Inc. (a) | Viking Therapeutics, Inc. (a) | &nbsp;&nbsp;44929 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1710896 |
| Vir Biotechnology, Inc. (a) | Vir Biotechnology, Inc. (a) | &nbsp;&nbsp;38417 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;228965 |
| Viridian Therapeutics, Inc. (a) | Viridian Therapeutics, Inc. (a) | &nbsp;&nbsp;27723 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;655095 |
| Xencor, Inc. (a) | Xencor, Inc. (a) | &nbsp;&nbsp;24743 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;363970 |
| Xenon Pharmaceuticals, Inc. (a) | Xenon Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;27388 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1148105 |
| Zymeworks, Inc. (a) | Zymeworks, Inc. (a) | &nbsp;&nbsp;15429 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;294462 |
| TOTAL BIOTECHNOLOGY | &nbsp;&nbsp;&nbsp;&nbsp;571542564 |  |  |
| **CONSUMER STAPLES DISTRIBUTION & RETAIL – 0.0%** | **CONSUMER STAPLES DISTRIBUTION & RETAIL – 0.0%** | **CONSUMER STAPLES DISTRIBUTION & RETAIL – 0.0%** | **CONSUMER STAPLES DISTRIBUTION & RETAIL – 0.0%** |
| **Drug Retail – 0.0%** | **Drug Retail – 0.0%** | **Drug Retail – 0.0%** | **Drug Retail – 0.0%** |
| Guardian Pharmacy Services, Inc. Class A (a) | Guardian Pharmacy Services, Inc. Class A (a) | &nbsp;&nbsp;&nbsp;&nbsp;8135 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;228105 |
| **HEALTH CARE EQUIPMENT & SUPPLIES – 20.5%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 20.5%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 20.5%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 20.5%** |
| **Health Care Equipment – 19.5%** | **Health Care Equipment – 19.5%** | **Health Care Equipment – 19.5%** | **Health Care Equipment – 19.5%** |
| Abbott Laboratories | Abbott Laboratories | 732868 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90597142 |
| Alphatec Holdings, Inc. (a) | Alphatec Holdings, Inc. (a) | &nbsp;&nbsp;48433 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;919743 |
| Artivion, Inc. (a) | Artivion, Inc. (a) | &nbsp;&nbsp;15071 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;683771 |
| AtriCure, Inc. (a) | AtriCure, Inc. (a) | &nbsp;&nbsp;20558 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;710279 |
| Axogen, Inc. (a) | Axogen, Inc. (a) | &nbsp;&nbsp;17617 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;391450 |
| Baxter International, Inc. | Baxter International, Inc. | 215954 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3988670 |
| Becton Dickinson & Co. | Becton Dickinson & Co. | 120752 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21579590 |
| Boston Scientific Corp. (a) | Boston Scientific Corp. (a) | 623184 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;62767092 |
| Ceribell, Inc. (a) | Ceribell, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7303 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;83254 |
| CONMED Corp. | CONMED Corp. | &nbsp;&nbsp;13199 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;580756 |
| Dexcom, Inc. (a) | Dexcom, Inc. (a) | 165014 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9607115 |
| Edwards Lifesciences Corp. (a) | Edwards Lifesciences Corp. (a) | 247209 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20382382 |
| Enovis Corp. (a) | Enovis Corp. (a) | &nbsp;&nbsp;24141 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;754165 |
| Envista Holdings Corp. (a) | Envista Holdings Corp. (a) | &nbsp;&nbsp;71516 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1455351 |
| GE HealthCare Technologies, Inc. | GE HealthCare Technologies, Inc. | 193043 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14468573 |
| Glaukos Corp. (a) | Glaukos Corp. (a) | &nbsp;&nbsp;24111 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2123456 |
| Globus Medical, Inc. Class A (a) | Globus Medical, Inc. Class A (a) | &nbsp;&nbsp;47659 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2878127 |
| Hologic, Inc. (a) | Hologic, Inc. (a) | &nbsp;&nbsp;94042 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6950644 |
| IDEXX Laboratories, Inc. (a) | IDEXX Laboratories, Inc. (a) | &nbsp;&nbsp;33885 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21330946 |
| Inspire Medical Systems, Inc. (a) | Inspire Medical Systems, Inc. (a) | &nbsp;&nbsp;11823 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;852202 |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Insulet Corp. (a) | Insulet Corp. (a) | &nbsp;&nbsp;29617 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$9270417 |
| Integer Holdings Corp. (a) | Integer Holdings Corp. (a) | &nbsp;&nbsp;14722 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;950600 |
| Integra LifeSciences Holdings Corp. (a) | Integra LifeSciences Holdings Corp. (a) | &nbsp;&nbsp;27497 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;330239 |
| Intuitive Surgical, Inc. (a) | Intuitive Surgical, Inc. (a) | 150976 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;80663457 |
| iRadimed Corp. | iRadimed Corp. | &nbsp;&nbsp;&nbsp;&nbsp;3526 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;270832 |
| iRhythm Technologies, Inc. (a) | iRhythm Technologies, Inc. (a) | &nbsp;&nbsp;13471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2523118 |
| LeMaitre Vascular, Inc. | LeMaitre Vascular, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;9057 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;784427 |
| LivaNova PLC (a) | LivaNova PLC (a) | &nbsp;&nbsp;23120 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1216806 |
| Masimo Corp. (a) | Masimo Corp. (a) | &nbsp;&nbsp;19341 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2720312 |
| Medtronic PLC | Medtronic PLC | 539704 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48951153 |
| Novocure Ltd. (a) | Novocure Ltd. (a) | &nbsp;&nbsp;44200 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;566202 |
| Omnicell, Inc. (a) | Omnicell, Inc. (a) | &nbsp;&nbsp;19485 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;654111 |
| Penumbra, Inc. (a) | Penumbra, Inc. (a) | &nbsp;&nbsp;15470 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3517414 |
| PROCEPT BioRobotics Corp. (a) | PROCEPT BioRobotics Corp. (a) | &nbsp;&nbsp;23347 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;794498 |
| Pulse Biosciences, Inc. (a) | Pulse Biosciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8530 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;144413 |
| QuidelOrtho Corp. (a) | QuidelOrtho Corp. (a) | &nbsp;&nbsp;28110 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;758689 |
| ResMed, Inc. | ResMed, Inc. | &nbsp;&nbsp;61802 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15257678 |
| SI-BONE, Inc. (a) | SI-BONE, Inc. (a) | &nbsp;&nbsp;15876 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;235441 |
| STERIS PLC | STERIS PLC | &nbsp;&nbsp;41398 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9757509 |
| Stryker Corp. | Stryker Corp. | 144881 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51612407 |
| Tandem Diabetes Care, Inc. (a) | Tandem Diabetes Care, Inc. (a) | &nbsp;&nbsp;27662 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;387268 |
| Teleflex, Inc. | Teleflex, Inc. | &nbsp;&nbsp;18597 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2314769 |
| TransMedics Group, Inc. (a) | TransMedics Group, Inc. (a) | &nbsp;&nbsp;13469 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1771712 |
| Zimmer Biomet Holdings, Inc. | Zimmer Biomet Holdings, Inc. | &nbsp;&nbsp;83262 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8372827 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;506931007 |
| **Health Care Supplies – 1.0%** | **Health Care Supplies – 1.0%** | **Health Care Supplies – 1.0%** | **Health Care Supplies – 1.0%** |
| Align Technology, Inc. (a) | Align Technology, Inc. (a) | &nbsp;&nbsp;29056 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4006241 |
| Avanos Medical, Inc. (a) | Avanos Medical, Inc. (a) | &nbsp;&nbsp;19249 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;213856 |
| Cooper Cos., Inc. (a) | Cooper Cos., Inc. (a) | &nbsp;&nbsp;84162 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5883765 |
| Dentsply Sirona, Inc. | Dentsply Sirona, Inc. | &nbsp;&nbsp;84489 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1065406 |
| Embecta Corp. | Embecta Corp. | &nbsp;&nbsp;23497 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;313450 |
| Establishment Labs Holdings, Inc. (a) | Establishment Labs Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7321 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;351042 |
| Haemonetics Corp. (a) | Haemonetics Corp. (a) | &nbsp;&nbsp;20270 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1013703 |
| ICU Medical, Inc. (a) | ICU Medical, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9857 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1183727 |
| Lantheus Holdings, Inc. (a) | Lantheus Holdings, Inc. (a) | &nbsp;&nbsp;29255 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1687721 |
| Merit Medical Systems, Inc. (a) | Merit Medical Systems, Inc. (a) | &nbsp;&nbsp;24883 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2178258 |
| Neogen Corp. (a) | Neogen Corp. (a) | &nbsp;&nbsp;85885 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;529911 |
| OrthoPediatrics Corp. (a) | OrthoPediatrics Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7085 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;119311 |
| Solventum Corp. (a) | Solventum Corp. (a) | &nbsp;&nbsp;65615 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4530060 |
| STAAR Surgical Co. (a) | STAAR Surgical Co. (a) | &nbsp;&nbsp;14545 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;376279 |
| UFP Technologies, Inc. (a) | UFP Technologies, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;3090 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;595258 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24047988 |
| TOTAL HEALTH CARE EQUIPMENT & SUPPLIES | &nbsp;&nbsp;&nbsp;&nbsp;530978995 |  |  |
| **HEALTH CARE PROVIDERS & SERVICES – 17.7%** | **HEALTH CARE PROVIDERS & SERVICES – 17.7%** | **HEALTH CARE PROVIDERS & SERVICES – 17.7%** | **HEALTH CARE PROVIDERS & SERVICES – 17.7%** |
| **Health Care Distributors – 3.5%** | **Health Care Distributors – 3.5%** | **Health Care Distributors – 3.5%** | **Health Care Distributors – 3.5%** |
| AdaptHealth Corp. (a) | AdaptHealth Corp. (a) | &nbsp;&nbsp;39860 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;358341 |
| Cardinal Health, Inc. | Cardinal Health, Inc. | 100444 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19161702 |
| Cencora, Inc. | Cencora, Inc. | &nbsp;&nbsp;77570 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26203922 |

---

---

| | |
|:---|:---|
| **3** | ***Quarterly Report*** |

---

------

Schedule of Investments (Unaudited)–continued

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **HEALTH CARE PROVIDERS & SERVICES – continued** | **HEALTH CARE PROVIDERS & SERVICES – continued** | **HEALTH CARE PROVIDERS & SERVICES – continued** |
| **Health Care Distributors – continued** | **Health Care Distributors – continued** | **Health Care Distributors – continued** |
| Henry Schein, Inc. (a) | &nbsp;&nbsp;47470 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$3000104 |
| McKesson Corp. | &nbsp;&nbsp;52697 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;42755184 |
| Owens & Minor, Inc. (a) | &nbsp;&nbsp;32673 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;129712 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;91608965 |
| **Health Care Facilities – 2.4%** | **Health Care Facilities – 2.4%** | **Health Care Facilities – 2.4%** |
| Acadia Healthcare Co., Inc. (a) | &nbsp;&nbsp;38814 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;834501 |
| Ardent Health, Inc. (a) | &nbsp;&nbsp;12072 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;175768 |
| Brookdale Senior Living, Inc. (a) | &nbsp;&nbsp;88997 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;825002 |
| Concentra Group Holdings Parent, Inc. | &nbsp;&nbsp;48004 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;956240 |
| Encompass Health Corp. | &nbsp;&nbsp;42419 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4829403 |
| Ensign Group, Inc. | &nbsp;&nbsp;24195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4357519 |
| HCA Healthcare, Inc. | &nbsp;&nbsp;76002 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34936599 |
| National HealthCare Corp. | &nbsp;&nbsp;&nbsp;&nbsp;5529 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;660384 |
| PACS Group, Inc. (a) | &nbsp;&nbsp;19471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;235210 |
| Select Medical Holdings Corp. | &nbsp;&nbsp;48867 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;675831 |
| Surgery Partners, Inc. (a) | &nbsp;&nbsp;32250 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;707243 |
| Tenet Healthcare Corp. (a) | &nbsp;&nbsp;39186 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8091517 |
| U.S. Physical Therapy, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;6337 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;546693 |
| Universal Health Services, Inc. Class B | &nbsp;&nbsp;24132 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5236885 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;63068795 |
| **Health Care Services – 4.4%** | **Health Care Services – 4.4%** | **Health Care Services – 4.4%** |
| Addus HomeCare Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7802 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;911976 |
| agilon health, Inc. (a) | 132893 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;105849 |
| AMN Healthcare Services, Inc. (a) | &nbsp;&nbsp;15772 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;310551 |
| Astrana Health, Inc. (a) | &nbsp;&nbsp;19193 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;599014 |
| Aveanna Healthcare Holdings, Inc. (a) | &nbsp;&nbsp;26112 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;236314 |
| BrightSpring Health Services, Inc. (a) | &nbsp;&nbsp;40936 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1352935 |
| Castle Biosciences, Inc. (a) | &nbsp;&nbsp;11627 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;296488 |
| Chemed Corp. | &nbsp;&nbsp;&nbsp;&nbsp;6160 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2656808 |
| Cigna Group | 112527 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27502724 |
| CorVel Corp. (a) | &nbsp;&nbsp;12987 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;960389 |
| CVS Health Corp. | 532859 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;41642931 |
| DaVita, Inc. (a) | &nbsp;&nbsp;17523 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2085587 |
| Fulgent Genetics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8038 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;180453 |
| GeneDx Holdings Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7827 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1071595 |
| Guardant Health, Inc. (a) | &nbsp;&nbsp;47140 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4384963 |
| Hims & Hers Health, Inc. (a) | &nbsp;&nbsp;81851 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3720946 |
| Hinge Health, Inc. Class A (a) | &nbsp;&nbsp;&nbsp;&nbsp;6785 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;337622 |
| Labcorp Holdings, Inc. | &nbsp;&nbsp;35224 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8945487 |
| LifeStance Health Group, Inc. (a) | &nbsp;&nbsp;56024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;274518 |
| NeoGenomics, Inc. (a) | &nbsp;&nbsp;53337 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;521102 |
| Nutex Health, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;1418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;174499 |
| OPKO Health, Inc. (a) | 184047 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;250304 |
| Option Care Health, Inc. (a) | &nbsp;&nbsp;69161 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1800261 |
| Pediatrix Medical Group, Inc. (a) | &nbsp;&nbsp;36253 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;615213 |
| Pennant Group, Inc. (a) | &nbsp;&nbsp;13985 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;345849 |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Premier, Inc. Class A | Premier, Inc. Class A | &nbsp;&nbsp;34743 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$976973 |
| Privia Health Group, Inc. (a) | Privia Health Group, Inc. (a) | &nbsp;&nbsp;41518 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1008887 |
| Quest Diagnostics, Inc. | Quest Diagnostics, Inc. | &nbsp;&nbsp;46981 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8266307 |
| RadNet, Inc. (a) | RadNet, Inc. (a) | &nbsp;&nbsp;27577 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2095576 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;113632121 |
| **Managed Health Care – 7.4%** | **Managed Health Care – 7.4%** | **Managed Health Care – 7.4%** | **Managed Health Care – 7.4%** |
| Alignment Healthcare, Inc. (a) | Alignment Healthcare, Inc. (a) | &nbsp;&nbsp;58438 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;985265 |
| Centene Corp. (a) | Centene Corp. (a) | 209977 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7426887 |
| Clover Health Investments Corp. (a) | Clover Health Investments Corp. (a) | 175761 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;620436 |
| Elevance Health, Inc. | Elevance Health, Inc. | &nbsp;&nbsp;95169 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30187607 |
| HealthEquity, Inc. (a) | HealthEquity, Inc. (a) | &nbsp;&nbsp;36468 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3449144 |
| Humana, Inc. | Humana, Inc. | &nbsp;&nbsp;50886 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14155976 |
| Molina Healthcare, Inc. (a) | Molina Healthcare, Inc. (a) | &nbsp;&nbsp;22869 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3500329 |
| Progyny, Inc. (a) | Progyny, Inc. (a) | &nbsp;&nbsp;34361 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;642894 |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | 382113 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;130514516 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;191483054 |
| TOTAL HEALTH CARE PROVIDERS & SERVICES | &nbsp;&nbsp;&nbsp;&nbsp;459792935 |  |  |
| **HEALTH CARE TECHNOLOGY – 1.0%** | **HEALTH CARE TECHNOLOGY – 1.0%** | **HEALTH CARE TECHNOLOGY – 1.0%** | **HEALTH CARE TECHNOLOGY – 1.0%** |
| **Health Care Technology – 1.0%** | **Health Care Technology – 1.0%** | **Health Care Technology – 1.0%** | **Health Care Technology – 1.0%** |
| Certara, Inc. (a) | Certara, Inc. (a) | &nbsp;&nbsp;51341 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;597096 |
| Doximity, Inc. Class A (a) | Doximity, Inc. Class A (a) | &nbsp;&nbsp;51991 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3431406 |
| Evolent Health, Inc. Class A (a) | Evolent Health, Inc. Class A (a) | &nbsp;&nbsp;41401 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;276145 |
| GoodRx Holdings, Inc. Class A (a) | GoodRx Holdings, Inc. Class A (a) | &nbsp;&nbsp;38464 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;129624 |
| HealthStream, Inc. | HealthStream, Inc. | &nbsp;&nbsp;10129 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;249173 |
| Phreesia, Inc. (a) | Phreesia, Inc. (a) | &nbsp;&nbsp;25108 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;568445 |
| Schrodinger, Inc. (a) | Schrodinger, Inc. (a) | &nbsp;&nbsp;27296 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;574308 |
| Teladoc Health, Inc. (a) | Teladoc Health, Inc. (a) | &nbsp;&nbsp;74558 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;643436 |
| Veeva Systems, Inc. Class A (a) | Veeva Systems, Inc. Class A (a) | &nbsp;&nbsp;65422 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19050886 |
| Waystar Holding Corp. (a) | Waystar Holding Corp. (a) | &nbsp;&nbsp;47480 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1702158 |
| TOTAL HEALTH CARE TECHNOLOGY | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27222677 |  |  |
| **LIFE SCIENCES TOOLS & SERVICES – 9.9%** | **LIFE SCIENCES TOOLS & SERVICES – 9.9%** | **LIFE SCIENCES TOOLS & SERVICES – 9.9%** | **LIFE SCIENCES TOOLS & SERVICES – 9.9%** |
| **Life Sciences Tools & Services – 9.9%** | **Life Sciences Tools & Services – 9.9%** | **Life Sciences Tools & Services – 9.9%** | **Life Sciences Tools & Services – 9.9%** |
| 10X Genomics, Inc. Class A (a) | 10X Genomics, Inc. Class A (a) | &nbsp;&nbsp;42289 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;576822 |
| Adaptive Biotechnologies Corp. (a) | Adaptive Biotechnologies Corp. (a) | &nbsp;&nbsp;45048 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;782033 |
| Agilent Technologies, Inc. | Agilent Technologies, Inc. | 119545 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17496606 |
| Avantor, Inc. (a) | Avantor, Inc. (a) | 287568 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3399054 |
| Azenta, Inc. (a) | Azenta, Inc. (a) | &nbsp;&nbsp;17263 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;521343 |
| BioLife Solutions, Inc. (a) | BioLife Solutions, Inc. (a) | &nbsp;&nbsp;17157 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;478166 |
| Bio-Rad Laboratories, Inc. Class A (a) | Bio-Rad Laboratories, Inc. Class A (a) | &nbsp;&nbsp;&nbsp;&nbsp;7941 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2537547 |
| Bio-Techne Corp. | Bio-Techne Corp. | &nbsp;&nbsp;66147 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4138818 |
| Bruker Corp. | Bruker Corp. | &nbsp;&nbsp;44931 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1749613 |
| Charles River Laboratories International, Inc. (a) | Charles River Laboratories International, Inc. (a) | &nbsp;&nbsp;20678 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3723487 |
| Danaher Corp. | Danaher Corp. | 271314 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58435609 |
| Ginkgo Bioworks Holdings, Inc. (a) | Ginkgo Bioworks Holdings, Inc. (a) | &nbsp;&nbsp;12629 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;164051 |
| Illumina, Inc. (a) | Illumina, Inc. (a) | &nbsp;&nbsp;66619 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8230111 |
| IQVIA Holdings, Inc. (a) | IQVIA Holdings, Inc. (a) | &nbsp;&nbsp;72805 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15759370 |
| Medpace Holdings, Inc. (a) | Medpace Holdings, Inc. (a) | &nbsp;&nbsp;10308 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6029252 |

---

 ***Quarterly Report*** <sub>4</sub>

------

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **LIFE SCIENCES TOOLS & SERVICES – continued** | **LIFE SCIENCES TOOLS & SERVICES – continued** | **LIFE SCIENCES TOOLS & SERVICES – continued** | **LIFE SCIENCES TOOLS & SERVICES – continued** |
| **Life Sciences Tools & Services – continued** | **Life Sciences Tools & Services – continued** | **Life Sciences Tools & Services – continued** | **Life Sciences Tools & Services – continued** |
| Mettler-Toledo International, Inc. (a) | Mettler-Toledo International, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8746 | &nbsp;&nbsp;&nbsp;&nbsp;$12386872 |
| Niagen Bioscience, Inc. (a) | Niagen Bioscience, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;23267 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;175433 |
| OmniAb, Inc. (a) | OmniAb, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1334 |
| OmniAb, Inc. (a) | OmniAb, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1067 |
| Repligen Corp. (a) | Repligen Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;22510 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3355341 |
| Revvity, Inc. | Revvity, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;49723 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4653576 |
| Sotera Health Co. (a) | Sotera Health Co. (a) | &nbsp;&nbsp;&nbsp;&nbsp;65146 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1081424 |
| Standard BioTools, Inc. (a) | Standard BioTools, Inc. (a) | &nbsp;&nbsp;&nbsp;108998 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;130798 |
| Tempus AI, Inc. (a) | Tempus AI, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;39006 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3504689 |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | &nbsp;&nbsp;&nbsp;159011 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90221251 |
| Waters Corp. (a) | Waters Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;25049 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8757130 |
| West Pharmaceutical Services, Inc. | West Pharmaceutical Services, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;30219 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8523873 |
| TOTAL LIFE SCIENCES TOOLS & SERVICES | &nbsp;&nbsp;&nbsp;&nbsp;256814670 |  |  |
| **PHARMACEUTICALS – 28.7%** | **PHARMACEUTICALS – 28.7%** | **PHARMACEUTICALS – 28.7%** | **PHARMACEUTICALS – 28.7%** |
| **Pharmaceuticals – 28.7%** | **Pharmaceuticals – 28.7%** | **Pharmaceuticals – 28.7%** | **Pharmaceuticals – 28.7%** |
| Amneal Pharmaceuticals, Inc. (a) | Amneal Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;65998 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;714098 |
| Amphastar Pharmaceuticals, Inc. (a) | Amphastar Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;16130 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;411315 |
| ANI Pharmaceuticals, Inc. (a) | ANI Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7187 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;651142 |
| Arvinas, Inc. (a) | Arvinas, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;24639 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;249839 |
| Avadel Pharmaceuticals PLC (a) | Avadel Pharmaceuticals PLC (a) | &nbsp;&nbsp;&nbsp;&nbsp;36200 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;683818 |
| Axsome Therapeutics, Inc. (a) | Axsome Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;14589 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1969369 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | &nbsp;&nbsp;&nbsp;857232 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39492678 |
| Collegium Pharmaceutical, Inc. (a) | Collegium Pharmaceutical, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;13513 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;486468 |
| Corcept Therapeutics, Inc. (a) | Corcept Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;40151 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2949894 |
| CorMedix, Inc. (a) | CorMedix, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;31274 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;348080 |
| Edgewise Therapeutics, Inc. (a) | Edgewise Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;22194 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;405706 |
| Elanco Animal Health, Inc. (a) | Elanco Animal Health, Inc. (a) | &nbsp;&nbsp;&nbsp;208868 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4626426 |
| Eli Lilly & Co. | Eli Lilly & Co. | &nbsp;&nbsp;&nbsp;339331 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;292795147 |
| Enliven Therapeutics, Inc. (a) | Enliven Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;13634 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;319308 |
| Evolus, Inc. (a) | Evolus, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;19698 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;127249 |
| Harmony Biosciences Holdings, Inc. (a) | Harmony Biosciences Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;17951 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;512860 |
| Harrow, Inc. (a) | Harrow, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;12907 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;487497 |
| Indivior PLC (a) | Indivior PLC (a) | &nbsp;&nbsp;&nbsp;&nbsp;42260 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1241176 |
| Innoviva, Inc. (a) | Innoviva, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;25105 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;456911 |
| Jazz Pharmaceuticals PLC (a) | Jazz Pharmaceuticals PLC (a) | &nbsp;&nbsp;&nbsp;&nbsp;24316 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3346854 |
| Johnson & Johnson | Johnson & Johnson | 1013505 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;191420689 |
| Ligand Pharmaceuticals, Inc. (a) | Ligand Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8196 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1567977 |
| Liquidia Corp. (a) | Liquidia Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;26944 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;656356 |
| Merck & Co., Inc. | Merck & Co., Inc. | 1057715 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90942336 |
| Mind Medicine MindMed, Inc. (a) | Mind Medicine MindMed, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;25994 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;369115 |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Nuvation Bio, Inc. (a) | Nuvation Bio, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;78733 | &nbsp;&nbsp;&nbsp;&nbsp;$410986 |
| Ocular Therapeutix, Inc. (a) | Ocular Therapeutix, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;66869 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;779693 |
| Organon & Co. | Organon & Co. | &nbsp;&nbsp;&nbsp;108809 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;734461 |
| Pacira BioSciences, Inc. (a) | Pacira BioSciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;19080 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;407930 |
| Perrigo Co. PLC | Perrigo Co. PLC | &nbsp;&nbsp;&nbsp;&nbsp;57739 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1197507 |
| Pfizer, Inc. | Pfizer, Inc. | 2394834 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59032658 |
| Phibro Animal Health Corp. Class A | Phibro Animal Health Corp. Class A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8577 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;360749 |
| Prestige Consumer Healthcare, Inc. (a) | Prestige Consumer Healthcare, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;20757 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1257874 |
| Royalty Pharma PLC Class A | Royalty Pharma PLC Class A | &nbsp;&nbsp;&nbsp;160018 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6007076 |
| SIGA Technologies, Inc. | SIGA Technologies, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;18770 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;155416 |
| Supernus Pharmaceuticals, Inc. (a) | Supernus Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;23329 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1286128 |
| Tarsus Pharmaceuticals, Inc. (a) | Tarsus Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;13296 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;914898 |
| Tilray Brands, Inc. (a) | Tilray Brands, Inc. (a) | &nbsp;&nbsp;&nbsp;439217 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;588551 |
| Trevi Therapeutics, Inc. (a) | Trevi Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;35192 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;410339 |
| Viatris, Inc. | Viatris, Inc. | &nbsp;&nbsp;&nbsp;495240 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5130686 |
| WaVe Life Sciences Ltd. (a) | WaVe Life Sciences Ltd. (a) | &nbsp;&nbsp;&nbsp;&nbsp;45409 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;410497 |
| Xeris Biopharma Holdings, Inc. (a) | Xeris Biopharma Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;67577 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;655497 |
| Zoetis, Inc. | Zoetis, Inc. | &nbsp;&nbsp;&nbsp;187539 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27022495 |
| TOTAL PHARMACEUTICALS | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;743995749 |  |  |
| **TOTAL COMMON STOCKS<br> (Cost $2,077,743,886)** | **TOTAL COMMON STOCKS<br> (Cost $2,077,743,886)** | **TOTAL COMMON STOCKS<br> (Cost $2,077,743,886)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2590575695** |
| &nbsp;&nbsp;**Money Market Fund – 0.1%** | &nbsp;&nbsp;**Money Market Fund – 0.1%** | &nbsp;&nbsp;**Money Market Fund – 0.1%** | &nbsp;&nbsp;**Money Market Fund – 0.1%** |
| State Street Institutional Treasury Plus Money Market Fund, Trust Class, 3.93% (b)<br> (Cost $3,504,000) | State Street Institutional Treasury Plus Money Market Fund, Trust Class, 3.93% (b)<br> (Cost $3,504,000) | 3504000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3504000 |
| **TOTAL INVESTMENT IN SECURITIES – 99.9%<br> (Cost $2,081,247,886)** | &nbsp;&nbsp;**2594079695** |  |  |
| **NET OTHER ASSETS (LIABILITIES) (c) – 0.1%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2550415** |  |  |
| **NET ASSETS – 100.0%** | **$2596630110** |  |  |

---

---

| | |
|:---|:---|
| **Legend** | **Legend** |
| (a) | Non-income producing. |
| (b) | The rate quoted is the annualized seven-day yield of the fund at period end. |
| (c) | Includes $281,448 of cash collateral to cover margin requirements for futures contracts. |

---

---

| | |
|:---|:---|
| **5** | ***Quarterly Report*** |

---

------

Schedule of Investments (Unaudited)–continued

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** |
|  | **Number of<br> contracts** | &nbsp;&nbsp;**Expiration<br> Date** | &nbsp;&nbsp;**Notional<br> Amount** | &nbsp;&nbsp;**Value** | &nbsp;&nbsp;**Unrealized<br> Appreciation/<br> (Depreciation)** |
| **Purchased** |  |  |  |  |  |
| **Equity Index Contracts** |  |  |  |  |  |
| CME E-mini Health Care Select Sector Index Contracts (United States) | 33 | &nbsp;&nbsp;December 2025 | &nbsp;&nbsp;4826250 | &nbsp;&nbsp;$123572 | &nbsp;&nbsp;$123572 |
| CME E-mini Russell 2000 Index Contracts (United States) | 3 | &nbsp;&nbsp;December 2025 | &nbsp;&nbsp;&nbsp;&nbsp;373485 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2434) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2434) |
| Total Equity Index Contracts |  |  |  |  | &nbsp;&nbsp;&nbsp;$121138 |

---

The notional amount of futures purchased as a percentage of Net Assets is 0.2%

#### Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.

The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:

Level 1 – unadjusted quoted prices in active markets for identical investments

Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 – unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy. If an unaffiliated open-end mutual fund's NAV is unavailable, shares of that fund may be valued by another method that the Board believes reflects fair value in accordance with the Board's fair value pricing policies and is categorized as Level 2 in the hierarchy.

 ***Quarterly Report*** <sub>6</sub>

------

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.

#### Derivative Instruments
Risk Exposures and the Use of Derivative Instruments: The Fund's investment objectives allow the Fund to enter into various types of derivative contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.

The Fund used derivatives to increase returns, to gain exposure to certain types of assets and/or to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.

The Fund's use of derivatives increased or decreased its exposure to the following risk(s):

Equity Risk - Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment.

Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.

Futures Contracts: A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a specified price at a specified future date.

The Fund used futures contracts to manage its exposure to the stock market.

Open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The underlying face amount at value reflects each contract's exposure to the underlying instrument or index at period end. Any securities and/or cash deposited to meet initial margin requirements are identified in the Schedule of Investments.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

---

| | |
|:---|:---|
| **7** | ***Quarterly Report*** |

---

------

*The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.*

*Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.* 

 ***Quarterly Report*** <sub>8</sub>

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** FIDELITY COVINGTON TRUST

- **b. Investment Company Act file number:** 811-07319

- **c. CIK number of Registrant:** 0000945908

- **d. LEI of Registrant:** 549300JFYFTF85QAQR28

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 245 SUMMER STREET

  - **City:** BOSTON

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02210

  - **Telephone number:** 1-800-FIDELITY

**Item A.2. Information about the Series.**

- **a. Name of Series:** Fidelity MSCI Health Care Index ETF

- **b. EDGAR series identifier (if any):** S000042575

- **c. LEI of Series:** 549300Y1NOU164X4H550

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-07-31

- **b. Date as of which information is reported:** 2025-10-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $2596811747.80

**Total Liabilities:** $184854.38

**Net Assets:** $2596626893.42

**Cash Not Reported:** $175393.85

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000131667 | 5.65%                | 2.25%                | 4.06%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $9260003.11              | $120323650.10                              |
| Month 2  | $746500.95               | $50804487.87                               |
| Month 3  | $10779800.90             | $87784001.54                               |

### Schedule of Portfolio Investments

| Name                                         | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| ADMA Biologics Inc                           | ADMA Biologics Inc                                         | CUSIP: 000899104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    100363 | NS      | $1553619.24   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| AMN Healthcare Services Inc                  | AMN Healthcare Services Inc                                | CUSIP: 001744101<br>LEI: 529900W3ARRTCNFH2I39 | Long             | EC               | CORP              | US        |     15772 | NS      | $310550.68    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ANI Pharmaceuticals Inc                      | ANI Pharmaceuticals Inc                                    | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |      7187 | NS      | $651142.20    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                          | Abbott Laboratories                                        | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    732868 | NS      | $90597142.16  | 3.49%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                   | AbbVie Inc                                                 | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    744059 | NS      | $162234624.36 | 6.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Acadia Healthcare Co Inc                     | Acadia Healthcare Co Inc                                   | CUSIP: 00404A109<br>LEI: 5493005CW985Y9D0NC11 | Long             | EC               | CORP              | US        |     38814 | NS      | $834501.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals Inc                   | ACADIA Pharmaceuticals Inc                                 | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |     49434 | NS      | $1122151.80   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp                | Adaptive Biotechnologies Corp                              | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |     45048 | NS      | $782033.28    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| AdaptHealth Corp                             | AdaptHealth Corp                                           | CUSIP: 00653Q102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39860 | NS      | $358341.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Addus HomeCare Corp                          | Addus HomeCare Corp                                        | CUSIP: 006739106<br>LEI: 52990090ZT33AKPDBX62 | Long             | EC               | CORP              | US        |      7802 | NS      | $911975.78    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Spyre Therapeutics Inc                       | Spyre Therapeutics Inc                                     | CUSIP: 00773J202<br>LEI: 52990017AIJPRH3HQH40 | Long             | EC               | CORP              | US        |     20597 | NS      | $503802.62    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc                     | Agilent Technologies Inc                                   | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |    119545 | NS      | $17496606.20  | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Agios Pharmaceuticals Inc                    | Agios Pharmaceuticals Inc                                  | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |     23216 | NS      | $1003859.84   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| agilon health Inc                            | agilon health Inc                                          | CUSIP: 00857U107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    132893 | NS      | $105849.27    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Akebia Therapeutics Inc                      | Akebia Therapeutics Inc                                    | CUSIP: 00972D105<br>LEI: 549300CBQEHMKEEGNX42 | Long             | EC               | CORP              | US        |    110819 | NS      | $244909.99    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics Inc                       | Akero Therapeutics Inc                                     | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |     23482 | NS      | $1272724.40   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA AKOUOS INC                            | CONTRA AKOUOS INC                                          | CUSIP: 009CVR036<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11863 | NS      | $2253.97      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Align Technology Inc                         | Align Technology Inc                                       | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |     29056 | NS      | $4006241.28   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Alignment Healthcare Inc                     | Alignment Healthcare Inc                                   | CUSIP: 01625V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     58438 | NS      | $985264.68    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                  | Alnylam Pharmaceuticals Inc                                | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     54926 | NS      | $25048453.04  | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphatec Holdings Inc                        | Alphatec Holdings Inc                                      | CUSIP: 02081G201<br>LEI: 549300EZE8CQ8K65FS24 | Long             | EC               | CORP              | US        |     48433 | NS      | $919742.67    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                                  | Cencora Inc                                                | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |     77570 | NS      | $26203921.70  | 1.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                    | Amgen Inc                                                  | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |    226497 | NS      | $67593499.71  | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Amicus Therapeutics Inc                      | Amicus Therapeutics Inc                                    | CUSIP: 03152W109<br>LEI: 549300MRD1SMUTNBPQ53 | Long             | EC               | CORP              | US        |    104332 | NS      | $942117.96    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Amneal Pharmaceuticals Inc                   | Amneal Pharmaceuticals Inc                                 | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |     65998 | NS      | $714098.36    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc                | Amphastar Pharmaceuticals Inc                              | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |     16130 | NS      | $411315.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                               | AnaptysBio Inc                                             | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |      5807 | NS      | $212420.06    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Anavex Life Sciences Corp                    | Anavex Life Sciences Corp                                  | CUSIP: 032797300<br>LEI: 549300K1I5L8COCQ8W36 | Long             | EC               | CORP              | US        |     35572 | NS      | $283508.84    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc                          | Elevance Health Inc                                        | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |     95169 | NS      | $30187606.80  | 1.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc                  | Apellis Pharmaceuticals Inc                                | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |     31703 | NS      | $680663.41    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Astrana Health Inc                           | Astrana Health Inc                                         | CUSIP: 03763A207<br>LEI: 5493008O4R82Q4STJ936 | Long             | EC               | CORP              | US        |     19193 | NS      | $599013.53    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc                      | Apogee Therapeutics Inc                                    | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13090 | NS      | $740763.10    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp                       | Arbutus Biopharma Corp                                     | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |     59302 | NS      | $280498.46    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                                  | Arcellx Inc                                                | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11625 | NS      | $1049156.25   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Ardelyx Inc                                  | Ardelyx Inc                                                | CUSIP: 039697107<br>LEI: 549300F542QR4SXHCY32 | Long             | EC               | CORP              | US        |    102181 | NS      | $619216.86    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc                        | Arcus Biosciences Inc                                      | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29041 | NS      | $572688.52    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcutis Biotherapeutics Inc                  | Arcutis Biotherapeutics Inc                                | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45276 | NS      | $1145935.56   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Ardent Health Inc                            | Ardent Health Inc                                          | CUSIP: 03980N107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12072 | NS      | $175768.32    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ArriVent Biopharma Inc                       | ArriVent Biopharma Inc                                     | CUSIP: 04272N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7743 | NS      | $145026.39    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals Inc                | Arrowhead Pharmaceuticals Inc                              | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |     46764 | NS      | $1982325.96   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                                  | Arvinas Inc                                                | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24639 | NS      | $249839.46    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| AtriCure Inc                                 | AtriCure Inc                                               | CUSIP: 04963C209<br>LEI: 254900B2I6GPHK2EXM59 | Long             | EC               | CORP              | US        |     20558 | NS      | $710278.90    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Aurinia Pharmaceuticals Inc                  | Aurinia Pharmaceuticals Inc                                | CUSIP: 05156V102<br>LEI: 5299008YP2BW4570ML28 | Long             | EC               | CORP              | CA        |     47865 | NS      | $630382.05    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Avanos Medical Inc                           | Avanos Medical Inc                                         | CUSIP: 05350V106<br>LEI: 549300YCXWOM7NEWMQ58 | Long             | EC               | CORP              | US        |     19249 | NS      | $213856.39    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Avantor Inc                                  | Avantor Inc                                                | CUSIP: 05352A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    287568 | NS      | $3399053.76   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Aveanna Healthcare Holdings Inc              | Aveanna Healthcare Holdings Inc                            | CUSIP: 05356F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     26112 | NS      | $236313.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Avidity Biosciences Inc                      | Avidity Biosciences Inc                                    | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45505 | NS      | $3178524.25   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Axogen Inc                                   | Axogen Inc                                                 | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17617 | NS      | $391449.74    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc                      | Axsome Therapeutics Inc                                    | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     14589 | NS      | $1969369.11   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Baxter International Inc                     | Baxter International Inc                                   | CUSIP: 071813109<br>LEI: J5OIVXX3P24RJRW5CK77 | Long             | EC               | CORP              | US        |    215954 | NS      | $3988670.38   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc                        | Beam Therapeutics Inc                                      | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     37764 | NS      | $944477.64    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton Dickinson & Co                        | Becton Dickinson & Co                                      | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |    120752 | NS      | $21579589.92  | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Rad Laboratories Inc                     | Bio-Rad Laboratories Inc                                   | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |      7941 | NS      | $2537546.55   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| BioCryst Pharmaceuticals Inc                 | BioCryst Pharmaceuticals Inc                               | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |     84378 | NS      | $617646.96    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                  | BioMarin Pharmaceutical Inc                                | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |     80707 | NS      | $4323473.99   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| BioLife Solutions Inc                        | BioLife Solutions Inc                                      | CUSIP: 09062W204<br>LEI: 549300G2IVCMC2TJDW72 | Long             | EC               | CORP              | US        |     17157 | NS      | $478165.59    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                   | Biogen Inc                                                 | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     61643 | NS      | $9509665.61   | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp                              | Bio-Techne Corp                                            | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |     66147 | NS      | $4138817.79   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp                       | Boston Scientific Corp                                     | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    623184 | NS      | $62767092.48  | 2.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                         | Bridgebio Pharma Inc                                       | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     60089 | NS      | $3763974.96   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| BrightSpring Health Services Inc             | BrightSpring Health Services Inc                           | CUSIP: 10950A106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     40936 | NS      | $1352934.80   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co                      | Bristol-Myers Squibb Co                                    | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    857232 | NS      | $39492678.24  | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Brookdale Senior Living Inc                  | Brookdale Senior Living Inc                                | CUSIP: 112463104<br>LEI: LH7MQB13NWY7CJ9VC445 | Long             | EC               | CORP              | US        |     88997 | NS      | $825002.19    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Azenta Inc                                   | Azenta Inc                                                 | CUSIP: 114340102<br>LEI: 35ZN6X1ANPH25YN32Y17 | Long             | EC               | CORP              | US        |     17263 | NS      | $521342.60    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Bruker Corp                                  | Bruker Corp                                                | CUSIP: 116794108<br>LEI: LEBZ6VLQ6I8XB1NHVY15 | Long             | EC               | CORP              | US        |     44931 | NS      | $1749613.14   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Group/The                              | Cigna Group/The                                            | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |    112527 | NS      | $27502724.07  | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                              | CVS Health Corp                                            | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    532859 | NS      | $41642930.85  | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health Inc                          | Cardinal Health Inc                                        | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |    100444 | NS      | $19161701.88  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| CareDx Inc                                   | CareDx Inc                                                 | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |     22165 | NS      | $332475.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Castle Biosciences Inc                       | Castle Biosciences Inc                                     | CUSIP: 14843C105<br>LEI: 2549007M2Q4HLR1XD252 | Long             | EC               | CORP              | US        |     11627 | NS      | $296488.50    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals Inc                 | Catalyst Pharmaceuticals Inc                               | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |     48802 | NS      | $1038018.54   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Celldex Therapeutics Inc                     | Celldex Therapeutics Inc                                   | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |     24989 | NS      | $667955.97    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Centene Corp                                 | Centene Corp                                               | CUSIP: 15135B101<br>LEI: 549300Z7JJ4TQSQGT333 | Long             | EC               | CORP              | US        |    209977 | NS      | $7426886.49   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Ceribell Inc                                 | Ceribell Inc                                               | CUSIP: 15678C102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7303 | NS      | $83254.20     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Certara Inc                                  | Certara Inc                                                | CUSIP: 15687V109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51341 | NS      | $597095.83    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                              | CG oncology Inc                                            | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17482 | NS      | $756446.14    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Charles River Laboratories International Inc | Charles River Laboratories International Inc               | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |     20678 | NS      | $3723487.46   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Chemed Corp                                  | Chemed Corp                                                | CUSIP: 16359R103<br>LEI: 54930020031IDJT2IM79 | Long             | EC               | CORP              | US        |      6160 | NS      | $2656808.00   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA CHINOOK THERAPE                       | CONTRA CHINOOK THERAPE                                     | CUSIP: 169CVR016<br>LEI: 549300X0O3003W5QYQ48 | Long             | EC               | CORP              | US        |     24218 | NS      | $0.24         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Niagen Bioscience Inc                        | Niagen Bioscience Inc                                      | CUSIP: 171077407<br>LEI: 529900OPI7B8JPXCVS70 | Long             | EC               | CORP              | US        |     23267 | NS      | $175433.18    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Cidara Therapeutics Inc                      | Cidara Therapeutics Inc                                    | CUSIP: 171757206<br>LEI: 549300IHQ9Z7RI1X2D22 | Long             | EC               | CORP              | US        |      4956 | NS      | $541393.44    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Clover Health Investments Corp               | Clover Health Investments Corp                             | CUSIP: 18914F103<br>LEI: 5493000HLYOYQU6LK133 | Long             | EC               | CORP              | US        |    175761 | NS      | $620436.33    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc                       | Cogent Biosciences Inc                                     | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     35296 | NS      | $575324.80    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Enovis Corp                                  | Enovis Corp                                                | CUSIP: 194014502<br>LEI: 635400OP2DYYYMOIYL17 | Long             | EC               | CORP              | US        |     24141 | NS      | $754164.84    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical Inc                 | Collegium Pharmaceutical Inc                               | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     13513 | NS      | $486468.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Concentra Group Holdings Parent Inc          | Concentra Group Holdings Parent Inc                        | CUSIP: 20603L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48004 | NS      | $956239.68    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| CONMED Corp                                  | CONMED Corp                                                | CUSIP: 207410101<br>LEI: Z6C0YCECH9DCU5ZIQW84 | Long             | EC               | CORP              | US        |     13199 | NS      | $580756.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The                           | Cooper Cos Inc/The                                         | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |     84162 | NS      | $5883765.42   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc                     | Corcept Therapeutics Inc                                   | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |     40151 | NS      | $2949893.97   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| CorMedix Inc                                 | CorMedix Inc                                               | CUSIP: 21900C308<br>LEI: 5299006YIA3L0MBW8358 | Long             | EC               | CORP              | US        |     31274 | NS      | $348079.62    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| QuidelOrtho Corp                             | QuidelOrtho Corp                                           | CUSIP: 219798105<br>LEI: 549300YU8CMO9HF53113 | Long             | EC               | CORP              | US        |     28110 | NS      | $758688.90    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| CorVel Corp                                  | CorVel Corp                                                | CUSIP: 221006109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12987 | NS      | $960388.65    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc                | Crinetics Pharmaceuticals Inc                              | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |     37212 | NS      | $1618722.00   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Artivion Inc                                 | Artivion Inc                                               | CUSIP: 228903100<br>LEI: 549300YTKV8DMSMG6K81 | Long             | EC               | CORP              | US        |     15071 | NS      | $683771.27    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Cullinan Therapeutics Inc                    | Cullinan Therapeutics Inc                                  | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10512 | NS      | $91033.92     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics Inc                             | Cytokinetics Inc                                           | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |     47944 | NS      | $3048758.96   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                                 | Danaher Corp                                               | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    271314 | NS      | $58435609.32  | 2.25%             |  |  |  | No            |                  1 | On Loan: No      |
| DaVita Inc                                   | DaVita Inc                                                 | CUSIP: 23918K108<br>LEI: M2XHYMU3TZNEZURC6H66 | Long             | EC               | CORP              | US        |     17523 | NS      | $2085587.46   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Day One Biopharmaceuticals Inc               | Day One Biopharmaceuticals Inc                             | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     27918 | NS      | $207709.92    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Denali Therapeutics Inc                      | Denali Therapeutics Inc                                    | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |     58235 | NS      | $948065.80    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| DENTSPLY SIRONA Inc                          | DENTSPLY SIRONA Inc                                        | CUSIP: 24906P109<br>LEI: 9NHEHR1SOZCYXDO8HO28 | Long             | EC               | CORP              | US        |     84489 | NS      | $1065406.29   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom Inc                                   | Dexcom Inc                                                 | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |    165014 | NS      | $9607115.08   | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Disc Medicine Inc                            | Disc Medicine Inc                                          | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9456 | NS      | $815296.32    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Doximity Inc                                 | Doximity Inc                                               | CUSIP: 26622P107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51991 | NS      | $3431406.00   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Dynavax Technologies Corp                    | Dynavax Technologies Corp                                  | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |     41248 | NS      | $423204.48    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Dyne Therapeutics Inc                        | Dyne Therapeutics Inc                                      | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39509 | NS      | $892113.22    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc                    | Edgewise Therapeutics Inc                                  | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22194 | NS      | $405706.32    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp                    | Edwards Lifesciences Corp                                  | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    247209 | NS      | $20382382.05  | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc                     | Elanco Animal Health Inc                                   | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |    208868 | NS      | $4626426.20   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Embecta Corp                                 | Embecta Corp                                               | CUSIP: 29082K105<br>LEI: 549300RPG8GXVDHNXZ62 | Long             | EC               | CORP              | US        |     23497 | NS      | $313449.98    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Encompass Health Corp                        | Encompass Health Corp                                      | CUSIP: 29261A100<br>LEI: 549300FVRPM9DRQZRG64 | Long             | EC               | CORP              | US        |     42419 | NS      | $4829403.15   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc                     | Enliven Therapeutics Inc                                   | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13634 | NS      | $319308.28    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Ensign Group Inc/The                         | Ensign Group Inc/The                                       | CUSIP: 29358P101<br>LEI: 5493003K4HEEA8Q0BC72 | Long             | EC               | CORP              | US        |     24195 | NS      | $4357519.50   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Envista Holdings Corp                        | Envista Holdings Corp                                      | CUSIP: 29415F104<br>LEI: 549300BX623VURJZ5269 | Long             | EC               | CORP              | US        |     71516 | NS      | $1455350.60   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolent Health Inc                           | Evolent Health Inc                                         | CUSIP: 30050B101<br>LEI: 549300CZOCFHQ2BBTR11 | Long             | EC               | CORP              | US        |     41401 | NS      | $276144.67    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolus Inc                                   | Evolus Inc                                                 | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |     19698 | NS      | $127249.08    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp                          | Exact Sciences Corp                                        | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |     79595 | NS      | $5149000.55   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis Inc                                 | Exelixis Inc                                               | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |    109316 | NS      | $4227249.72   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Standard BioTools Inc                        | Standard BioTools Inc                                      | CUSIP: 34385P108<br>LEI: 549300GX8Y96GSB6YP89 | Long             | EC               | CORP              | US        |    108998 | NS      | $130797.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Fulgent Genetics Inc                         | Fulgent Genetics Inc                                       | CUSIP: 359664109<br>LEI: 549300CL6P01M68QJ404 | Long             | EC               | CORP              | US        |      8038 | NS      | $180453.10    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| GE HealthCare Technologies Inc               | GE HealthCare Technologies Inc                             | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |    193043 | NS      | $14468572.85  | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Geron Corp                                   | Geron Corp                                                 | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |    195055 | NS      | $245769.30    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                          | Gilead Sciences Inc                                        | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    523977 | NS      | $62767204.83  | 2.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Ginkgo Bioworks Holdings Inc                 | Ginkgo Bioworks Holdings Inc                               | CUSIP: 37611X209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12629 | NS      | $164050.71    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Glaukos Corp                                 | Glaukos Corp                                               | CUSIP: 377322102<br>LEI: 5299004JA1LHE21M6T14 | Long             | EC               | CORP              | US        |     24111 | NS      | $2123455.77   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Globus Medical Inc                           | Globus Medical Inc                                         | CUSIP: 379577208<br>LEI: 5299003M2P4CIK0RF205 | Long             | EC               | CORP              | US        |     47659 | NS      | $2878127.01   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| GoodRx Holdings Inc                          | GoodRx Holdings Inc                                        | CUSIP: 38246G108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     38464 | NS      | $129623.68    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| GRAIL Inc                                    | GRAIL Inc                                                  | CUSIP: 384747101<br>LEI: 2549009XSNESW3VE8024 | Long             | EC               | CORP              | US        |     15395 | NS      | $1415262.35   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                          | Guardant Health Inc                                        | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     47140 | NS      | $4384962.80   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Healthcare Inc                           | HCA Healthcare Inc                                         | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |     76002 | NS      | $34936599.36  | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Haemonetics Corp                             | Haemonetics Corp                                           | CUSIP: 405024100<br>LEI: 549300ZEL6TXZS6F5F95 | Long             | EC               | CORP              | US        |     20270 | NS      | $1013702.70   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                    | Halozyme Therapeutics Inc                                  | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |     52078 | NS      | $3394964.82   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Harmony Biosciences Holdings Inc             | Harmony Biosciences Holdings Inc                           | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17951 | NS      | $512860.07    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Harrow Inc                                   | Harrow Inc                                                 | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12907 | NS      | $487497.39    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| HealthStream Inc                             | HealthStream Inc                                           | CUSIP: 42222N103<br>LEI: 529900OJ88H8635JNH64 | Long             | EC               | CORP              | US        |     10129 | NS      | $249173.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| HealthEquity Inc                             | HealthEquity Inc                                           | CUSIP: 42226A107<br>LEI: 529900LRJU1RAFQHM467 | Long             | EC               | CORP              | US        |     36468 | NS      | $3449143.44   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Hims & Hers Health Inc                       | Hims & Hers Health Inc                                     | CUSIP: 433000106<br>LEI: 254900V041EIVTSB6D58 | Long             | EC               | CORP              | US        |     81851 | NS      | $3720946.46   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Hinge Health Inc                             | Hinge Health Inc                                           | CUSIP: 433313103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6785 | NS      | $337621.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Hologic Inc                                  | Hologic Inc                                                | CUSIP: 436440101<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |     94042 | NS      | $6950644.22   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                                   | Humana Inc                                                 | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     50886 | NS      | $14155976.34  | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| ICU Medical Inc                              | ICU Medical Inc                                            | CUSIP: 44930G107<br>LEI: 5493003NRW7LS2QZRH60 | Long             | EC               | CORP              | US        |      9857 | NS      | $1183727.13   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| iRhythm Technologies Inc                     | iRhythm Technologies Inc                                   | CUSIP: 450056106<br>LEI: 549300FJI72RJGDQS384 | Long             | EC               | CORP              | US        |     13471 | NS      | $2523118.30   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc                       | Ideaya Biosciences Inc                                     | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |     33057 | NS      | $1053196.02   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc                       | IDEXX Laboratories Inc                                     | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     33885 | NS      | $21330946.35  | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                 | Illumina Inc                                               | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |     66619 | NS      | $8230111.26   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| ImmunityBio Inc                              | ImmunityBio Inc                                            | CUSIP: 45256X103<br>LEI: 529900J9XLBR4HFL4B83 | Long             | EC               | CORP              | US        |    111727 | NS      | $268144.80    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunome Inc                                 | Immunome Inc                                               | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30018 | NS      | $482389.26    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                               | Immunovant Inc                                             | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     28224 | NS      | $696568.32    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                  | Incyte Corp                                                | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     69243 | NS      | $6472835.64   | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                   | Insmed Inc                                                 | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     80095 | NS      | $15186012.00  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Inspire Medical Systems Inc                  | Inspire Medical Systems Inc                                | CUSIP: 457730109<br>LEI: 549300XQQCQ7HCJKTW25 | Long             | EC               | CORP              | US        |     11823 | NS      | $852201.84    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva Inc                                 | Innoviva Inc                                               | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |     25105 | NS      | $456911.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Insulet Corp                                 | Insulet Corp                                               | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |     29617 | NS      | $9270417.17   | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Integra LifeSciences Holdings Corp           | Integra LifeSciences Holdings Corp                         | CUSIP: 457985208<br>LEI: WB7IJCYY8YFTENS4O147 | Long             | EC               | CORP              | US        |     27497 | NS      | $330238.97    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Integer Holdings Corp                        | Integer Holdings Corp                                      | CUSIP: 45826H109<br>LEI: 549300SUD2ED5XG6X569 | Long             | EC               | CORP              | US        |     14722 | NS      | $950599.54    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                    | Intellia Therapeutics Inc                                  | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     41469 | NS      | $523338.78    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc                       | Intuitive Surgical Inc                                     | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |    150976 | NS      | $80663457.28  | 3.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals Inc                    | Ionis Pharmaceuticals Inc                                  | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |     63610 | NS      | $4726223.00   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics Inc                  | Iovance Biotherapeutics Inc                                | CUSIP: 462260100<br>LEI: 2549002L8WT2ACU5Q878 | Long             | EC               | CORP              | US        |    110465 | NS      | $217616.05    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| iRadimed Corp                                | iRadimed Corp                                              | CUSIP: 46266A109<br>LEI: 549300YVHWP0YJ1YW816 | Long             | EC               | CORP              | US        |      3526 | NS      | $270832.06    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                           | IQVIA Holdings Inc                                         | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     72805 | NS      | $15759370.30  | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics Inc                       | Janux Therapeutics Inc                                     | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16230 | NS      | $465963.30    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                            | Johnson & Johnson                                          | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |   1013505 | NS      | $191420689.35 | 7.37%             |  |  |  | No            |                  1 | On Loan: No      |
| KalVista Pharmaceuticals Inc                 | KalVista Pharmaceuticals Inc                               | CUSIP: 483497103<br>LEI: 529900Q7IDA3WUGRZA51 | Long             | EC               | CORP              | US        |     10539 | NS      | $114980.49    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech Inc                          | Krystal Biotech Inc                                        | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      9196 | NS      | $1816301.96   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Kura Oncology Inc                            | Kura Oncology Inc                                          | CUSIP: 50127T109<br>LEI: 5493005QORQTZCZYOP39 | Long             | EC               | CORP              | US        |     29225 | NS      | $300140.75    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Kymera Therapeutics Inc                      | Kymera Therapeutics Inc                                    | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17763 | NS      | $1098463.92   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Labcorp Holdings Inc                         | Labcorp Holdings Inc                                       | CUSIP: 504922105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     35224 | NS      | $8945487.04   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantheus Holdings Inc                        | Lantheus Holdings Inc                                      | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |     29255 | NS      | $1687720.95   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| LeMaitre Vascular Inc                        | LeMaitre Vascular Inc                                      | CUSIP: 525558201<br>LEI: 549300FZUBUB7MHY8R17 | Long             | EC               | CORP              | US        |      9057 | NS      | $784426.77    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| LENZ Therapeutics Inc                        | LENZ Therapeutics Inc                                      | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4920 | NS      | $146222.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc                   | Ligand Pharmaceuticals Inc                                 | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      8196 | NS      | $1567976.76   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| LifeStance Health Group Inc                  | LifeStance Health Group Inc                                | CUSIP: 53228F101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     56024 | NS      | $274517.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                               | Eli Lilly & Co                                             | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    339331 | NS      | $292795146.66 | 11.28%            |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp                                | Liquidia Corp                                              | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     26944 | NS      | $656355.84    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                 | Madrigal Pharmaceuticals Inc                               | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      6107 | NS      | $2558222.30   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| MannKind Corp                                | MannKind Corp                                              | CUSIP: 56400P706<br>LEI: 213800GFBCNY1ZFST722 | Long             | EC               | CORP              | US        |    119390 | NS      | $667390.10    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Masimo Corp                                  | Masimo Corp                                                | CUSIP: 574795100<br>LEI: 549300Q4A8JK0PIYCU29 | Long             | EC               | CORP              | US        |     19341 | NS      | $2720311.65   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| McKesson Corp                                | McKesson Corp                                              | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |     52697 | NS      | $42755183.98  | 1.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Pediatrix Medical Group Inc                  | Pediatrix Medical Group Inc                                | CUSIP: 58502B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36253 | NS      | $615213.41    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Medpace Holdings Inc                         | Medpace Holdings Inc                                       | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |     10308 | NS      | $6029252.28   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                               | Merck & Co Inc                                             | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |   1057715 | NS      | $90942335.70  | 3.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Merit Medical Systems Inc                    | Merit Medical Systems Inc                                  | CUSIP: 589889104<br>LEI: 549300OYTY138SP2CE83 | Long             | EC               | CORP              | US        |     24883 | NS      | $2178257.82   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Metsera Inc                                  | Metsera Inc                                                | CUSIP: 59267L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8845 | NS      | $557588.80    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Mettler-Toledo International Inc             | Mettler-Toledo International Inc                           | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |      8746 | NS      | $12386872.34  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| MiMedx Group Inc                             | MiMedx Group Inc                                           | CUSIP: 602496101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48307 | NS      | $369548.55    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine MindMed Inc                    | Mind Medicine MindMed Inc                                  | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | CA        |     25994 | NS      | $369114.80    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Mineralys Therapeutics Inc                   | Mineralys Therapeutics Inc                                 | CUSIP: 603170101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19288 | NS      | $788107.68    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc                    | Mirum Pharmaceuticals Inc                                  | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |     15656 | NS      | $1137408.40   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                  | Moderna Inc                                                | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    146480 | NS      | $3978396.80   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Molina Healthcare Inc                        | Molina Healthcare Inc                                      | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |     22869 | NS      | $3500329.14   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics                  | MoonLake Immunotherapeutics                                | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |      9252 | NS      | $93445.20     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Myriad Genetics Inc                          | Myriad Genetics Inc                                        | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |     37957 | NS      | $305174.28    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                   | Natera Inc                                                 | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     54591 | NS      | $10859787.63  | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| National HealthCare Corp                     | National HealthCare Corp                                   | CUSIP: 635906100<br>LEI: 254900PTS11LS1JS2752 | Long             | EC               | CORP              | US        |      5529 | NS      | $660383.76    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Neogen Corp                                  | Neogen Corp                                                | CUSIP: 640491106<br>LEI: 549300HJT9FC36N4UW43 | Long             | EC               | CORP              | US        |     85885 | NS      | $529910.45    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| NeoGenomics Inc                              | NeoGenomics Inc                                            | CUSIP: 64049M209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     53337 | NS      | $521102.49    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                   | Neurocrine Biosciences Inc                                 | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     41649 | NS      | $5964553.29   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Novavax Inc                                  | Novavax Inc                                                | CUSIP: 670002401<br>LEI: 529900J4GJHPEPQ23205 | Long             | EC               | CORP              | US        |     60231 | NS      | $505940.40    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                                 | Nuvalent Inc                                               | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16727 | NS      | $1661325.64   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Nutex Health Inc                             | Nutex Health Inc                                           | CUSIP: 67079U306<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1418 | NS      | $174499.08    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc                       | Nurix Therapeutics Inc                                     | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     31794 | NS      | $411414.36    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                             | Nuvation Bio Inc                                           | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     78733 | NS      | $410986.26    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Ocular Therapeutix Inc                       | Ocular Therapeutix Inc                                     | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |     66869 | NS      | $779692.54    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Omnicell Inc                                 | Omnicell Inc                                               | CUSIP: 68213N109<br>LEI: 5493008RH0GTKHHPZI77 | Long             | EC               | CORP              | US        |     19485 | NS      | $654111.45    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| OMNIAB INC                                   | OMNIAB INC                                                 | CUSIP: 68218J202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3335 | NS      | $1334.00      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| OMNIAB INC                                   | OMNIAB INC                                                 | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3335 | NS      | $1067.20      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| OPKO Health Inc                              | OPKO Health Inc                                            | CUSIP: 68375N103<br>LEI: 529900A4S2D4OGOJLL02 | Long             | EC               | CORP              | US        |    184047 | NS      | $250303.92    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Option Care Health Inc                       | Option Care Health Inc                                     | CUSIP: 68404L201<br>LEI: 549300DI3Q5ACSYJRI17 | Long             | EC               | CORP              | US        |     69161 | NS      | $1800260.83   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| ORIC Pharmaceuticals Inc                     | ORIC Pharmaceuticals Inc                                   | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |     14385 | NS      | $189306.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                                 | Organon & Co                                               | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    108809 | NS      | $734460.75    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| OrthoPediatrics Corp                         | OrthoPediatrics Corp                                       | CUSIP: 68752L100<br>LEI: 5493000KUTPFGOPAT717 | Long             | EC               | CORP              | US        |      7085 | NS      | $119311.40    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Owens & Minor Inc                            | Owens & Minor Inc                                          | CUSIP: 690732102<br>LEI: 549300LMT5KQQXCEZ733 | Long             | EC               | CORP              | US        |     32673 | NS      | $129711.81    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics Inc                         | PTC Therapeutics Inc                                       | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |     29926 | NS      | $2044245.06   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| PACS Group Inc                               | PACS Group Inc                                             | CUSIP: 69380Q107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19471 | NS      | $235209.68    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira BioSciences Inc                       | Pacira BioSciences Inc                                     | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19080 | NS      | $407930.40    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Pennant Group Inc/The                        | Pennant Group Inc/The                                      | CUSIP: 70805E109<br>LEI: 5493007H2OYR6BYLDA64 | Long             | EC               | CORP              | US        |     13985 | NS      | $345849.05    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Penumbra Inc                                 | Penumbra Inc                                               | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |     15470 | NS      | $3517413.90   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Revvity Inc                                  | Revvity Inc                                                | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |     49723 | NS      | $4653575.57   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                                   | Pfizer Inc                                                 | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   2394834 | NS      | $59032658.10  | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Phibro Animal Health Corp                    | Phibro Animal Health Corp                                  | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |      8577 | NS      | $360748.62    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Phreesia Inc                                 | Phreesia Inc                                               | CUSIP: 71944F106<br>LEI: 5493000HHF8NU4QOCG53 | Long             | EC               | CORP              | US        |     25108 | NS      | $568445.12    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines Inc               | Praxis Precision Medicines Inc                             | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8663 | NS      | $1721857.88   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Premier Inc                                  | Premier Inc                                                | CUSIP: 74051N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34743 | NS      | $976973.16    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc             | Prestige Consumer Healthcare Inc                           | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20757 | NS      | $1257874.20   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| PROCEPT BioRobotics Corp                     | PROCEPT BioRobotics Corp                                   | CUSIP: 74276L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23347 | NS      | $794498.41    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Privia Health Group Inc                      | Privia Health Group Inc                                    | CUSIP: 74276R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     41518 | NS      | $1008887.40   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Progyny Inc                                  | Progyny Inc                                                | CUSIP: 74340E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34361 | NS      | $642894.31    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc                 | Protagonist Therapeutics Inc                               | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21023 | NS      | $1652828.26   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Pulse Biosciences Inc                        | Pulse Biosciences Inc                                      | CUSIP: 74587B101<br>LEI: 529900NJUBI06118FM73 | Long             | EC               | CORP              | US        |      8530 | NS      | $144412.90    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Quest Diagnostics Inc                        | Quest Diagnostics Inc                                      | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     46981 | NS      | $8266306.95   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| RadNet Inc                                   | RadNet Inc                                                 | CUSIP: 750491102<br>LEI: 529900RECG94V2IZJ970 | Long             | EC               | CORP              | US        |     27577 | NS      | $2095576.23   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc                | Recursion Pharmaceuticals Inc                              | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    135049 | NS      | $745470.48    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                | Regeneron Pharmaceuticals Inc                              | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     44717 | NS      | $29146540.60  | 1.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics Inc                       | Relay Therapeutics Inc                                     | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48685 | NS      | $347610.90    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corp                                | Repligen Corp                                              | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |     22510 | NS      | $3355340.60   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Replimune Group Inc                          | Replimune Group Inc                                        | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |     16211 | NS      | $157733.03    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ResMed Inc                                   | ResMed Inc                                                 | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |     61802 | NS      | $15257677.76  | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc                     | Revolution Medicines Inc                                   | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |     58758 | NS      | $3457320.72   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                   | Rhythm Pharmaceuticals Inc                                 | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |     22275 | NS      | $2534004.00   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Sana Biotechnology Inc                       | Sana Biotechnology Inc                                     | CUSIP: 799566104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     57103 | NS      | $282659.85    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc                     | Sarepta Therapeutics Inc                                   | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |     36784 | NS      | $883183.84    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Henry Schein Inc                             | Henry Schein Inc                                           | CUSIP: 806407102<br>LEI: VGO3WGL8H45T73F4RR92 | Long             | EC               | CORP              | US        |     47470 | NS      | $3000104.00   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp                    | Scholar Rock Holding Corp                                  | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |     26041 | NS      | $771334.42    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Schrodinger Inc/United States                | Schrodinger Inc/United States                              | CUSIP: 80810D103<br>LEI: 984500044BAE4791E559 | Long             | EC               | CORP              | US        |     27296 | NS      | $574307.84    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Select Medical Holdings Corp                 | Select Medical Holdings Corp                               | CUSIP: 81619Q105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48867 | NS      | $675830.61    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| GeneDx Holdings Corp                         | GeneDx Holdings Corp                                       | CUSIP: 81663L200<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7827 | NS      | $1071594.57   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| SI-BONE Inc                                  | SI-BONE Inc                                                | CUSIP: 825704109<br>LEI: 549300J8JGYVJJHV9C31 | Long             | EC               | CORP              | US        |     15876 | NS      | $235441.08    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| SIGA Technologies Inc                        | SIGA Technologies Inc                                      | CUSIP: 826917106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18770 | NS      | $155415.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ARS Pharmaceuticals Inc                      | ARS Pharmaceuticals Inc                                    | CUSIP: 82835W108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18721 | NS      | $167740.16    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics Inc                      | Soleno Therapeutics Inc                                    | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |     16693 | NS      | $1121101.88   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Solventum Corp                               | Solventum Corp                                             | CUSIP: 83444M101<br>LEI: 254900I70403OSGY4M28 | Long             | EC               | CORP              | US        |     65615 | NS      | $4530059.60   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Sotera Health Co                             | Sotera Health Co                                           | CUSIP: 83601L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     65146 | NS      | $1081423.60   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| STAAR Surgical Co                            | STAAR Surgical Co                                          | CUSIP: 852312305<br>LEI: 5299006LRHI7OJ8BY308 | Long             | EC               | CORP              | US        |     14545 | NS      | $376279.15    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Stoke Therapeutics Inc                       | Stoke Therapeutics Inc                                     | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |     16125 | NS      | $484395.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                                 | Stryker Corp                                               | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |    144881 | NS      | $51612407.44  | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals Inc                 | Supernus Pharmaceuticals Inc                               | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |     23329 | NS      | $1286127.77   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Surgery Partners Inc                         | Surgery Partners Inc                                       | CUSIP: 86881A100<br>LEI: 549300LC82HG33S19I03 | Long             | EC               | CORP              | US        |     32250 | NS      | $707242.50    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc                   | Syndax Pharmaceuticals Inc                                 | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |     34493 | NS      | $472554.10    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Tandem Diabetes Care Inc                     | Tandem Diabetes Care Inc                                   | CUSIP: 875372203<br>LEI: 549300JEPFOD0K4D3I05 | Long             | EC               | CORP              | US        |     27662 | NS      | $387268.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc                   | Tarsus Pharmaceuticals Inc                                 | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13296 | NS      | $914897.76    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Teladoc Health Inc                           | Teladoc Health Inc                                         | CUSIP: 87918A105<br>LEI: 549300I2PVFBC9MFAC61 | Long             | EC               | CORP              | US        |     74558 | NS      | $643435.54    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Teleflex Inc                                 | Teleflex Inc                                               | CUSIP: 879369106<br>LEI: UUL85LWXB4NGSWWXIQ25 | Long             | EC               | CORP              | US        |     18597 | NS      | $2314768.59   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Tempus AI Inc                                | Tempus AI Inc                                              | CUSIP: 88023B103<br>LEI: 2549009LA0KWRAGQBX50 | Long             | EC               | CORP              | US        |     39006 | NS      | $3504689.10   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics Inc                             | 10X Genomics Inc                                           | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |     42289 | NS      | $576821.96    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Tenet Healthcare Corp                        | Tenet Healthcare Corp                                      | CUSIP: 88033G407<br>LEI: 0W9AIBT6U6ADJ2I8HK17 | Long             | EC               | CORP              | US        |     39186 | NS      | $8091517.14   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics Inc                          | TG Therapeutics Inc                                        | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |     63168 | NS      | $2196983.04   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                 | Thermo Fisher Scientific Inc                               | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |    159011 | NS      | $90221251.29  | 3.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Tilray Brands Inc                            | Tilray Brands Inc                                          | CUSIP: 88688T100<br>LEI: 549300Y4V60733TO1478 | Long             | EC               | CORP              | US        |    439217 | NS      | $588550.78    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| TransMedics Group Inc                        | TransMedics Group Inc                                      | CUSIP: 89377M109<br>LEI: 549300060GVOSMWARH50 | Long             | EC               | CORP              | US        |     13469 | NS      | $1771712.26   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc                     | Travere Therapeutics Inc                                   | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     35768 | NS      | $1257602.88   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Trevi Therapeutics Inc                       | Trevi Therapeutics Inc                                     | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     35192 | NS      | $410338.72    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp                        | Twist Bioscience Corp                                      | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |     25383 | NS      | $834846.87    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| UFP Technologies Inc                         | UFP Technologies Inc                                       | CUSIP: 902673102<br>LEI: 549300RJ8LY41HS70C91 | Long             | EC               | CORP              | US        |      3090 | NS      | $595257.60    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| US Physical Therapy Inc                      | US Physical Therapy Inc                                    | CUSIP: 90337L108<br>LEI: 529900KL1UXQYFIOMY96 | Long             | EC               | CORP              | US        |      6337 | NS      | $546692.99    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                | Ultragenyx Pharmaceutical Inc                              | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     35583 | NS      | $1231171.80   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp                     | United Therapeutics Corp                                   | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     18081 | NS      | $8053819.83   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                       | UnitedHealth Group Inc                                     | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    382113 | NS      | $130514516.28 | 5.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Health Services Inc                | Universal Health Services Inc                              | CUSIP: 913903100<br>LEI: 549300YGMGQDO0NMJD09 | Long             | EC               | CORP              | US        |     24132 | NS      | $5236885.32   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                                  | Vaxcyte Inc                                                | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |     48813 | NS      | $2210252.64   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems Inc                            | Veeva Systems Inc                                          | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |     65422 | NS      | $19050886.40  | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Veracyte Inc                                 | Veracyte Inc                                               | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |     33263 | NS      | $1200129.04   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Vera Therapeutics Inc                        | Vera Therapeutics Inc                                      | CUSIP: 92337R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17492 | NS      | $497822.32    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Vericel Corp                                 | Vericel Corp                                               | CUSIP: 92346J108<br>LEI: 54930076YM3PLTDR4B91 | Long             | EC               | CORP              | US        |     21054 | NS      | $738153.24    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                   | Vertex Pharmaceuticals Inc                                 | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |    108170 | NS      | $46033906.90  | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                                  | Viatris Inc                                                | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    495240 | NS      | $5130686.40   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc                      | Viking Therapeutics Inc                                    | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |     44929 | NS      | $1710896.32   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc                        | Vir Biotechnology Inc                                      | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     38417 | NS      | $228965.32    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics Inc                    | Viridian Therapeutics Inc                                  | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |     27723 | NS      | $655094.49    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| State Street Global Advisors                 | State Street Institutional Treasury Plus Money Market Fund | CUSIP: 857492862<br>LEI: 549300PNASLVKQG64331 | Long             | STIV             | RF                | US        |   3504000 | NS      | $3504000.00   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                                  | Waters Corp                                                | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |     25049 | NS      | $8757130.40   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Waystar Holding Corp                         | Waystar Holding Corp                                       | CUSIP: 946784105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     47480 | NS      | $1702158.00   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| West Pharmaceutical Services Inc             | West Pharmaceutical Services Inc                           | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |     30219 | NS      | $8523873.33   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor Inc                                   | Xencor Inc                                                 | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |     24743 | NS      | $363969.53    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc                    | Xenon Pharmaceuticals Inc                                  | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |     27388 | NS      | $1148104.96   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings Inc                 | Xeris Biopharma Holdings Inc                               | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     67577 | NS      | $655496.90    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                   | Zimmer Biomet Holdings Inc                                 | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |     83262 | NS      | $8372826.72   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc                                   | Zoetis Inc                                                 | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    187539 | NS      | $27022494.51  | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                                | Zymeworks Inc                                              | CUSIP: 98985Y108<br>LEI: 894500AHOYAGYLYZJL67 | Long             | EC               | CORP              | US        |     15429 | NS      | $294462.47    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Chicago Mercantile Exchange                  | E-MINI RUSS 2000 DEC25                                     | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |         3 | NC      | $-2434.46     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Chicago Mercantile Exchange                  | XAV HEALTH CARE DEC25                                      | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |        33 | NC      | $123572.23    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                                 | Alkermes PLC                                               | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     65956 | NS      | $2024849.20   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                                 | Biohaven Ltd                                               | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | VG        |     36087 | NS      | $620696.40    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC                   | Avadel Pharmaceuticals PLC                                 | CUSIP: 000000000<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | IE        |     36200 | NS      | $683818.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Establishment Labs Holdings Inc              | Establishment Labs Holdings Inc                            | CUSIP: 000000000<br>LEI: 549300BCBQ714JNJ7V58 | Long             | EC               | CORP              | VG        |      7321 | NS      | $351041.95    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Indivior PLC                                 | Indivior PLC                                               | CUSIP: 000000000<br>LEI: 213800V3NCQTY7IED471 | Long             | EC               | CORP              | GB        |     42260 | NS      | $1241176.20   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC                     | Jazz Pharmaceuticals PLC                                   | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     24316 | NS      | $3346854.24   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Kiniksa Pharmaceuticals International Plc    | Kiniksa Pharmaceuticals International Plc                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | GB        |     14259 | NS      | $527725.59    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| LivaNova PLC                                 | LivaNova PLC                                               | CUSIP: 000000000<br>LEI: 2138001K2FX6SHK2B339 | Long             | EC               | CORP              | GB        |     23120 | NS      | $1216805.60   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                                | Medtronic PLC                                              | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    539704 | NS      | $48951152.80  | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Novocure Ltd                                 | Novocure Ltd                                               | CUSIP: 000000000<br>LEI: 213800YPP55UMHWA4826 | Long             | EC               | CORP              | JE        |     44200 | NS      | $566202.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd                         | Roivant Sciences Ltd                                       | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |    129082 | NS      | $2580349.18   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                           | Royalty Pharma PLC                                         | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    160018 | NS      | $6007075.72   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| STERIS PLC                                   | STERIS PLC                                                 | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     41398 | NS      | $9757508.60   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                               | Perrigo Co PLC                                             | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |     57739 | NS      | $1197506.86   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                       | CRISPR Therapeutics AG                                     | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |     34687 | NS      | $2219621.13   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Merus NV                                     | Merus NV                                                   | CUSIP: 000000000<br>LEI: 549300W8GPUWU8QNU293 | Long             | EC               | CORP              | NL        |     21999 | NS      | $2086825.14   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Newamsterdam Pharma Co NV                    | Newamsterdam Pharma Co NV                                  | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |     19479 | NS      | $739228.05    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                                   | uniQure NV                                                 | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |     16578 | NS      | $1122164.82   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd                       | WaVe Life Sciences Ltd                                     | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |     45409 | NS      | $410497.36    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-12-01

**Name of Applicant:** FIDELITY COVINGTON TRUST

**Signature:** Stacie M Smith

**Name of Signer:** Stacie M Smith

**Title:** President and Treasurer